QIAGEN NV's ticker is QGEN and the CUSIP is N72482123. A total of 2 filers reported holding QIAGEN NV in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $243,972 | -10.1% | 6,024 | 0.0% | 0.01% | -10.0% |
| Q2 2023 | $271,261 | -2.0% | 6,024 | 0.0% | 0.01% | -16.7% |
| Q1 2023 | $276,683 | -7.9% | 6,024 | 0.0% | 0.01% | -14.3% |
| Q4 2022 | $300,417 | +21.6% | 6,024 | +0.7% | 0.01% | +7.7% |
| Q3 2022 | $247,000 | -12.4% | 5,983 | 0.0% | 0.01% | -13.3% |
| Q2 2022 | $282,000 | -3.8% | 5,983 | 0.0% | 0.02% | +7.1% |
| Q1 2022 | $293,000 | -12.0% | 5,983 | 0.0% | 0.01% | -6.7% |
| Q4 2021 | $333,000 | +7.8% | 5,983 | 0.0% | 0.02% | -6.2% |
| Q3 2021 | $309,000 | +6.9% | 5,983 | 0.0% | 0.02% | +6.7% |
| Q2 2021 | $289,000 | -0.7% | 5,983 | 0.0% | 0.02% | -11.8% |
| Q1 2021 | $291,000 | +2.5% | 5,983 | +11.2% | 0.02% | -5.6% |
| Q4 2020 | $284,000 | +1.1% | 5,382 | 0.0% | 0.02% | -14.3% |
| Q3 2020 | $281,000 | +22.2% | 5,382 | 0.0% | 0.02% | +5.0% |
| Q2 2020 | $230,000 | – | 5,382 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| C M BIDWELL & ASSOCIATES LTD | 301,504 | $8,448,000 | 1.99% |
| PRIMECAP MANAGEMENT CO/CA/ | 19,143,036 | $536,388,000 | 0.53% |
| Granahan Investment Management | 535,700 | $15,010,000 | 0.52% |
| FRONTIER CAPITAL MANAGEMENT CO LLC | 1,704,116 | $47,749,000 | 0.37% |
| BALYASNY ASSET MANAGEMENT L.P. | 914,759 | $25,608,000 | 0.14% |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC | 626,250 | $17,548,000 | 0.02% |
| BALYASNY ASSET MANAGEMENT L.P. | 153,700 | $4,303,000 | 0.02% |
| Capital Research Global Investors | 2,259,565 | $63,393,000 | 0.02% |
| RHUMBLINE ADVISERS | 201,388 | $5,643,000 | 0.01% |
| TUDOR INVESTMENT CORP ET AL | 16,373 | $459,000 | 0.01% |